PFHOOTCServices-Misc Health & Allied Services, NECFiscal year ends December 31
PACIFIC HEALTH CARE ORGANIZATION INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$0.94+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $12.05M
- P/E (TTM)
- 10.4
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
–
Operating margin
14.9%+1.3 pts over 5 years
Net margin
20.7%+11.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +10.7% | +5.3% | +2.1% | -2.0% | |
| Operating income | +17.4% | +14.5% | +4.1% | -9.8% | |
| Net income | +57.0% | +41.2% | +20.4% | -1.9% | |
| EPS, diluted | +57.1% | +40.1% | +22.4% | -1.8% | |
| Free cash flow | +70.8% | +19.2% | +4.0% | -5.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.4% | 5.8% | 11.2% | |
| Return on assets | 9.6% | 5.1% | 10.7% | |
| Current ratio | 12.03 | 10.21 | 34.45 | |
| Debt to equity | – | 0.02 | – | |
| Net debt to EBITDA | – | -10.68× | – | |
| Interest coverage | – | – | 657.7× | |
| Capex to revenue | 0.7% | 0.9% | 0.3% | |
| Diluted shares | 13M | 13M | 13M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Pacific Health Care Organization generated $3.87M from operations and spent $1.43M on capital expenditure, dividends and share buybacks. 8% of that went back into the business.
Generated
$3.87M
Used
$1.43M
Capital expenditure$107.17K8%Dividends$1.32M92%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin20.7%
×Asset turnover0.52×
×Equity multiplier1.05×
=Return on equity, FY202511.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 20.7% | 0.52× | 1.05× | 11.2% |
| FY2024 | 14.6% | 0.50× | 1.08× | 7.9% |
| FY2023 | 13.6% | 0.47× | 1.08× | 6.9% |
| FY2022 | 8.6% | 0.49× | 1.06× | 4.5% |
| FY2021 | 18.4% | 0.48× | 1.09× | 9.6% |
| FY2020 | 9.1% | 0.57× | 1.12× | 5.8% |
| FY2019 | 16.3% | 0.78× | 1.08× | 13.8% |
| FY2018 | 20.0% | 0.86× | 1.07× | 18.4% |
| FY2017 | 14.8% | 0.96× | 1.08× | 15.5% |
| FY2016 | 10.0% | 0.97× | 1.08× | 10.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.39M
- Cash generatingOperating cash flow above zero$1.16M
- Return on assets improvedROA up on the prior year7.5% → 11.2%
- Earnings backed by cashOperating cash flow above net income$1.16M vs $1.39M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose16.54 → 34.45
- No dilutionShare count did not rise13M → 13M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.52 → 0.54